http://www.acc.org/Feed?clinicalTopicID=a111dd2d-31c2-4097-b779-01457a536a5e Clinical Topic Feed: Cardio-Oncology en /Latest-in-Cardiology/Articles/2026/08/03/15/28/Cardiotoxicity-Risk Immune checkpoint inhibitors (ICIs) are revolutionary oncologic therapies used frontline in several malignant neoplasms, including non–small cell lung cancer, melanoma, renal cell carcinoma, bladder cancer, and colorectal cancer. 1785780720000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1785581280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/26/13/15/Ten-Points-to-Remember Pediatric cardio-oncology has expanded in scope over the past several decades to address the ever-increasing issues related to cardiovascular disease (CVD) in patients with and survivors of cancer, related both to treatment modalities and the disease itself. 1779816420000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/12/10/54/Management-of-Checkpoint-Inhibitor-Myocarditis-in-the-CCU A 75-year-old man with a history of remote anterior ST-segment elevation myocardial infarction and stage IV malignant melanoma treated with combination immunotherapy (ipilimumab/nivolumab) presented to the oncology clinic with 3 days of exertional dyspnea and 24 hours of diplopia and neck weakness. 1773320700000 Articles and Stories /Latest-in-Cardiology/Articles/2026/01/23/18/21/The-Role-of-Exercise-in-Cardio-Oncology As cancer survival rates improve due to advances in treatment, new challenges have emerged; one of the most serious is cancer therapy–related cardiac dysfunction (CTRCD) and subsequent cardiovascular disease (CVD) among survivors of cancer. 1769429520000 Articles and Stories /Latest-in-Cardiology/Articles/2026/01/06/18/47/eagles-eye-view-07jan2025 In this episode, Dr. Eagle looks back at 2025 and explores some of the significant developments that show how the College is responding to changes in the way we evaluate, manage, and follow patients with various types of cardiovascular disorders. 1767798000000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/19/18/18/Top-ACC-Content-in-2025 The most popular ACC.org content items of 2025. 1766455200000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/17/14/32/eagles-eye-view-17dec2025 In this week’s View, Dr. Eagle looks at the DANISH trial extended follow-up, evaluating which patients benefit most from primary prevention implantable cardioverter defibrillator (ICD) implantation. 1765982040000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2025/12/10/15/38/ACC-Issues-Guidance-For-Managing-CV-Risks-Associated-With-Cancer-Treatments With modern cancer therapeutics changing the landscape of cancer treatment, the need to address cardiovascular treatment-related complications is increasingly important. 1765381740000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/10/15/28/Secondary-Cardiovascular-Prevention-For-Survivors-of-Childhood-Cancer Approximately half a million people in the United States are survivors of cancer diagnosed in childhood or adolescence. Over 50% of pediatric cancer patients have been treated with curative, but cardiotoxic, anthracycline-based therapies. 1762798560000 Articles and Stories